These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Off-label prescribing explained. Why your doctor may recommend meds that aren't FDA-approved for your condition. Johns Hopkins Med Lett Health After 50; 2011 Jun; 23(4):7. PubMed ID: 21702115 [No Abstract] [Full Text] [Related]
4. The accelerated drug approval. Novack GD Ocul Surf; 2010 Oct; 8(4):205-7. PubMed ID: 20964983 [No Abstract] [Full Text] [Related]
5. United States v. Caronia: Off-Label Drug Promotion and First Amendment Balancing. Rabinowitz DP Fordham Law Rev; 2018 Apr; 86(5):2595-623. PubMed ID: 29993225 [TBL] [Abstract][Full Text] [Related]
7. Timing of Pediatric Drug Approval and Clinical Evidence Submitted to Regulatory Authorities: International Comparison Among Japan, the United States, and the European Union. Hirota S; Yamaguchi T Clin Pharmacol Ther; 2020 Nov; 108(5):985-994. PubMed ID: 31869436 [TBL] [Abstract][Full Text] [Related]
8. Pharmaceuticals and medical devices: FDA oversight. ; Berry MD Issue Brief Health Policy Track Serv; 2012 Jan; ():1-86. PubMed ID: 22403845 [No Abstract] [Full Text] [Related]
10. Off-label, not off-limits: the FDA needs to create a safe harbor for off-label drug use. Howard P; Copland J Mo Med; 2013; 110(2):106-9. PubMed ID: 23724473 [No Abstract] [Full Text] [Related]
16. The future of off-label marketing regulations in the post-Sorrell era. Iraggi J Seton Hall Law Rev; 2013; 43(3):1137-63. PubMed ID: 23802338 [No Abstract] [Full Text] [Related]